Clinical trial · no report yet · Phase 2
PERICLES
PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study
- NCT03686332 ↗
- Completed
- The Netherlands Cancer Institute
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 7 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- PERICLES (PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study)-a Phase 2 Study of Atezolizumab With or Without Radiotherapy in Penile Cancer
- Phase
- Phase 2
- Status
- Completed
- Conditions
- Penile Cancer
- Interventions
- Arm A: Atezolizumab and Radiotherapy; Arm B: Atezolizumab
- Arms
- Arm A: Atezolizumab and Radiotherapy · Other
- Arm B: Atezolizumab · Other
- Enrollment
- 32
- Primary outcomes
- Progression-free survival at 1 year.
- Sponsor
- The Netherlands Cancer Institute with Hoffmann-La Roche
- Start
- Sep 25, 2018
- Primary completion
- Sep 28, 2022
- Results posted
- No
- Registry record
- NCT03686332 · updated Sep 21, 2023
Publications
linked from the registry- de Vries HM, Rafael TS, Gil-Jimenez A, de Feijter JM, Bekers E, van der Laan E, Lopez-Yurda M, Hooijberg E, Broeks A, Peters D, Seignette IM, Pos FJ, Horenblas S, van Rhijn BWG, Jordanova ES, Brouwer OR, Schaake E, van der Heijden MS. Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. J Clin Oncol. 2023 Nov 1;41(31):4872-4880. doi: 10.1200/JCO.22.02894. Epub 2023 Jul 24. PubMed 37487169